상세 보기
Clinicopathologic Characteristics of CD99-Positive Diffuse Large B-Cell Lymphoma
- Lee, Sang Pyo;
- Park, Sanghui;
- Park, Jinny;
- Hong, Junshik;
- Ko, Young Hyeh
WEB OF SCIENCE
10SCOPUS
12초록
Background: CD99 immunoreactivity has been documented in a variety of tumors, including lymphoid malignancies such as anaplastic large-cell lymphomas. However, few studies have investigated the prognostic impact of CD99 in diffuse large B-cell lymphoma (DLBCL). Methods: Using conventional paraffin embedding, immunoperoxidase staining and tissue microarrays, we retrospectively investigated CD99 expression in 155 DLBCL patients. Results: Of the 155 DLBCL patients, 60 (38.7%) were positive for CD99. CD99 positivity was significantly associated with advanced stage (p < 0.01), higher risk group according to the International Prognostic Index risk score (p < 0.01) and non-germinal center B cell-like type (p = 0.01). The difference in progression-free survival (PFS) between CD99+ and CD99- groups was statistically significant (p = 0.04), even though the difference in overall survival was not (p = 0.74). Multivariate analysis demonstrated that CD99 expression was marginally correlated with PFS. Conclusion: To the best of our knowledge, this is the first report on the clinicopathologic characteristics of CD99+ DLBCL, particularly unique clinicopathologic features. Copyright (C) 2010 S. Karger AG, Basel
키워드
- 제목
- Clinicopathologic Characteristics of CD99-Positive Diffuse Large B-Cell Lymphoma
- 저자
- Lee, Sang Pyo; Park, Sanghui; Park, Jinny; Hong, Junshik; Ko, Young Hyeh
- 발행일
- 2011-03
- 유형
- Article
- 권
- 125
- 호
- 3
- 페이지
- 167 ~ 174
- 언어
- ENG
- 출판사
- S. Karger AG
- 발행국가
- 스위스
- 분량
- 8 페이지
- ISSN
- E 1421-9662
P 0001-5792